ORIGINAL ARTICLE |
|
Year : 2012 | Volume
: 16
| Issue : 3 | Page : 406-408 |
|
Incidence of gall stone formation in acromegalic patients on octreotide therapy
Aditi A Chakravarty1, Ajay Ajmani1, Smita Manchanda2, Bindu Kulshreshtha1, Shweta Chopra1
1 Department of Endocrinology, Dr. Ram Manohar Lohia Hospital, New Delhi, India 2 Department of Radiology, Dr. Ram Manohar Lohia Hospital, New Delhi, India
Correspondence Address:
Ajay Ajmani Department of Endocrinology, Dr. Ram Manohar Lohia Hospital, New Delhi India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.95683
|
|
Objective: Octreotide, a long-acting synthetic somatostatin analog, has been widely used for ac-romegalic patients. Gastrointestinal (GI) side effects and gall stones are predominant side effects. We report incidence of gall stones in our cohort of acromegalic patients treated with octreotide therapy. Design: Retrospective case observational study. Setting: Endocrinology Unit, Dr. Ram Manohar Lohia, Hospital, New Delhi. Materials and Methods: Patients of acromegaly on primary or secondary octreotide therapy. Intervention: Patients were enquired regarding complaints related to the GI system and their medical records were reviewed. Ultrasound films at various intervals while on octerotide therapy were evaluated by the radiologist for presence of sludge and development of gall stones. Results: Of seven patients, five developed gallstones and sludge was seen in three patients at intervals ranging from 11 to 36 months postoctreotide initiation. Conclusion: A high incidence of gall stone formation in the present study as compared to the West was noted, the reasons for which are not clear. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|